- $2.11bn
- $1.87bn
- $1.29bn
Progyny Q2 revenue rises 5%, slightly beats estimates
Brief: Progyny Q2 EPS USD 0.34
U.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
Progyny Q1 revenue slightly beats estimates, raises FY outlook
Brief: Progyny Issues Notice Of Pendency Of Settlement Of Derivative Action
U.S. RESEARCH ROUNDUP- Howmet Aerospace, Nike, Oracle
Progyny Q4 revenue rises 6.7%, beats expectations
Brief: Progyny Q4 EPS USD 0.14
U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals
Brief: Progyny To Discuss Updated Financial Expectations At Upcoming JP Morgan Healthcare Conference
Brief: Progyny Inc Anticipates Q4 And Full Year Results To Be Slightly Above Previously Provided Financial Guidance
U.S. RESEARCH ROUNDUP-Applied Materials Inc, Blackstone Mortgage, Brookdale Senior Living
Progyny Q3 revenue beats expectations on robust member engagement, authorises $200 mln share buyback
Brief: Progyny Q3 EPS USD 0.15
U.S. STOCKS ON THE MOVE-Bitfarms, Progyny, ManpowerGroup
Progyny climbs after report of White House IVF proposal
Advisory: Alert tagged to Progyny withdrawn
Progyny Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-BTCS, BrainStorm Cell, Moderna